Clough Capital Partners’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-43,700
Closed -$487K 136
2025
Q2
$487K Sell
43,700
-133,771
-75% -$1.66M 0.05% 112
2025
Q1
$2.89M Sell
177,471
-3,450
-2% -$60.6K 0.36% 57
2024
Q4
$3.16M Buy
180,921
+47,600
+36% +$828K 0.36% 60
2024
Q3
$2.08M Buy
133,321
+14,370
+12% +$230K 0.21% 67
2024
Q2
$1.58M Sell
118,951
-3,739
-3% -$51.2K 0.17% 69
2024
Q1
$1.78M Sell
122,690
-13,410
-10% -$185K 0.2% 69
2023
Q4
$1.83M Buy
+136,100
New +$1.6M 0.2% 84

Other funds holding OFIX

Clough Capital Partners's OFIX Position: Q3 2025 in Review

Clough Capital Partners sold out of Orthofix Medical (OFIX) in Q3 2025, closing a stake of 43,700 shares — an estimated $487K sold.

Clough Capital Partners first reported a position in OFIX in Q4 2023 and held it in 7 quarters. The position peaked at $3.16M in Q4 2024. 145 funds tracked by Wall St. Rank hold OFIX as of Q3 2025.

  • Clough Capital Partners reported no remaining Orthofix Medical position as of Q3 2025 after selling out during the quarter.
  • Clough Capital Partners sold 43,700 Orthofix Medical shares in Q3 2025, an estimated $487K.
  • Clough Capital Partners first reported a position in Orthofix Medical in Q4 2023 and held it in 7 quarters.
  • Clough Capital Partners's Orthofix Medical position peaked at $3.16M in Q4 2024.
  • 145 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2025.

Based on Clough Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.